Trial intelligence / Profile preview

Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients

NCT02404168Phase 4Completed

Sponsor
University of Maryland, Baltimore
Start
Jul 2015
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lamotrigine in epilepsy, sponsored by University of Maryland, Baltimore. Started Jul 2015; status: completed.

02

Drugs

lamotrigine
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT02404168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02404168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call